OICR News / Tag

Sagi Abelson

Browse news tagged Sagi Abelson.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyDiagnosis

Innovative tool pinpoints rare mutations that indicate the earliest phases of leukemia development

Dr. Sagi Abelson, OICR Investigator, Assistant Professor at the University of Toronto and first author of the publication. The tool can accurately distinguish real mutations from sequencing mistakes to improve the early detection of cancer…

ArticleDec 09, 2020

TalentBlood cancers

OICR welcomes new Principal Investigator, Dr. Sagi Abelson

Dr. Sagi Abelson, OICR Principal Investigator. OICR is proud to welcome Dr. Sagi Abelson to its Computational Biology Program as a Principal Investigator. Here, Abelson discusses some of his past successes, including his recent leukemia…

ArticleApr 18, 2019

TechnologyDiagnosis

Researchers find early indicators of leukemia in genomes up to 10 years before symptoms surfaced

Acute myeloid leukemia (AML) progresses quickly and requires treatment soon after diagnosis, but the disease begins long before becoming symptomatic. Early indicators of AML were thought to be indistinguishable from healthy aging. But now, an…

ArticleJul 10, 2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Sagi Abelson

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Innovative tool pinpoints rare mutations that indicate the earliest phases of leukemia development

OICR welcomes new Principal Investigator, Dr. Sagi Abelson

Researchers find early indicators of leukemia in genomes up to 10 years before symptoms surfaced

Cancer solved together — in your inbox